Press releases 22 Aug 2025 DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa
Statements 21 Aug 2025 DNDi’s briefing note for the 75th Session of the World Health Organization Regional Committee for Africa
In the media 8 Aug 2025 China deploys ‘cannibal’ mosquitoes and killer fish to fight chikungunya The Telegraph
News 8 Aug 2025 Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem
News 5 Aug 2025 ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific
Press releases 23 Jul 2025 AN2 Therapeutics and DNDi collaborate on clinical development of promising new oral compound to treat chronic Chagas disease
In the media 22 Jul 2025 Non-profits wade in where for-profit life science investment fears to tread Nature Biotechnology
Press releases 30 Jan 2025 DNDi welcomes GHIT support for new collaboration with Eisai for dengue and Zika virus disease
Press releases 30 Jan 2025 IRD, DNDi and Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
Press releases 5 Dec 2023 Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa
Press releases 3 Dec 2023 Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases
